Diabetes & Vascular
-
Should PCSK9 inhibitors (PCSK9i) be classified as statin medications that are used in clinical measure calculation, given their shared ability to reduce LDL cholesterol levels?
Updated: Monday, November 13, 2023
-
DDS Acceptable Blood Pressure Readings for Quality Measures
Updated: Tuesday, May 7, 2024
-
Diabetes measure: Is an A1c result from a home test kit acceptable for reporting?
Updated: Tuesday, August 1, 2023 a1c diabetes hba1c home test lab
-
Diabetes measure: Should a patient who has Gestational Diabetes be included in the data submission?
Updated: Friday, July 10, 2020 diabetes
-
Is a patient who meets inclusion criteria for IVD measure and also has Gestational Diabetes considered to have a co-morbidity of diabetes?
Updated: Tuesday, July 7, 2020 comorbidity cycle a diabetes gestational diabetes ivd ovc vascular
-
Is Fenofibrate lipid lowering medication an acceptable replacement for statin?
Updated: Friday, July 10, 2020 diabetes fenofibrate odc ovc statin vascular
-
Statin Exceptions, Aspirin Exceptions and Additional Medication FAQs
Updated: Wednesday, August 4, 2021 asa aspirin aspirin exceptions diabetes statin statin exceptions vascular
-
Vascular measure: Will MNCM retain the Optimal Vascular Care measure that was removed from SQRMS?
Updated: Tuesday, December 29, 2020 optimal vascular care ovc vascular
-
When the triglycerides are too high to calculate the LDL, our lab will typically do a measured LDL. Can we submit the measured/calculated LDL value rather than leaving it blank?
Updated: Friday, July 10, 2020 diabetes lab ldl odc ovc vascular
-
Is Repatha an allowable substitution for a Statin Medication?
Updated: Tuesday, October 5, 2021 diabetes exception medication odc ovc repatha repatha (evolocumab) statin vascular